US Eye Health Supplements Market

ID: MRFR/HC/17819-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
US Eye Health Supplements Market Research Report By Ingredient Type (Lutein and Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin, Others), By Form (Capsules/Tablets, Liquid, Gummies, Softgel, Powder), By Application (Age-related Macular Degeneration, Cataract, Glaucoma, Eye Fatigue, Corneal Support, Eyelid Conjunctivitis, Others) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets, E-Commerce) - Growth & Industry Forecast 2025 To 2035
US Eye Health Supplements Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.05%
2024 Market Size$ 508.2 Million
2025 Market Size$ 537.6 Million
2035 Market Size$ 970.2 Million
Key Players
Bausch + Lomb
Alcon
Johnson & Johnson
Nutrafol
EyePromise
Visionary Health
Trends
  • Rising Consumer Awareness
  • Innovative Product Formulations
  • Aging Population Influence
Opportunities
  • Rising Incidence of Eye Disorders
  • Increased Focus on Preventive Healthcare
  • Growing E-commerce and Online Retail Channels
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Application (USD Million)
      1. 4.1.1 Vision Improvement
      2. 4.1.2 Eye Fatigue Relief
      3. 4.1.3 Macular Degeneration Prevention
      4. 4.1.4 Dry Eye Relief
      5. 4.1.5 General Eye Health
    2. 4.2 Healthcare, BY Formulation (USD Million)
      1. 4.2.1 Capsules
      2. 4.2.2 Tablets
      3. 4.2.3 Powders
      4. 4.2.4 Liquids
      5. 4.2.5 Gummies
    3. 4.3 Healthcare, BY Distribution Channel (USD Million)
      1. 4.3.1 Online Retail
      2. 4.3.2 Pharmacies
      3. 4.3.3 Health Food Stores
      4. 4.3.4 Supermarkets
      5. 4.3.5 Specialty Stores
    4. 4.4 Healthcare, BY Target Demographic (USD Million)
      1. 4.4.1 Adults
      2. 4.4.2 Seniors
      3. 4.4.3 Children
      4. 4.4.4 Athletes
      5. 4.4.5 Professionals
    5. 4.5 Healthcare, BY Ingredient Type (USD Million)
      1. 4.5.1 Vitamins
      2. 4.5.2 Minerals
      3. 4.5.3 Herbal Extracts
      4. 4.5.4 Antioxidants
      5. 4.5.5 Omega Fatty Acids
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Bausch + Lomb (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Alcon (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Johnson & Johnson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Nutrafol (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 EyePromise (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Visionary Health (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Ocuvite (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Nature's Way (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 GNC (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY APPLICATION
    3. 6.3 US MARKET ANALYSIS BY FORMULATION
    4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    5. 6.5 US MARKET ANALYSIS BY TARGET DEMOGRAPHIC
    6. 6.6 US MARKET ANALYSIS BY INGREDIENT TYPE
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY FORMULATION, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY FORMULATION, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY TARGET DEMOGRAPHIC, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY TARGET DEMOGRAPHIC, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY INGREDIENT TYPE, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY INGREDIENT TYPE, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY FORMULATION, 2026-2035 (USD Million)
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
      4. 7.2.4 BY TARGET DEMOGRAPHIC, 2026-2035 (USD Million)
      5. 7.2.5 BY INGREDIENT TYPE, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US US Eye Health Supplements Market Segmentation

US Eye Health Supplements Market By Application (USD Million, 2026-2035)

  • Vision Improvement
  • Eye Fatigue Relief
  • Macular Degeneration Prevention
  • Dry Eye Relief
  • General Eye Health

US Eye Health Supplements Market By Formulation (USD Million, 2026-2035)

  • Capsules
  • Tablets
  • Powders
  • Liquids
  • Gummies

US Eye Health Supplements Market By Distribution Channel (USD Million, 2026-2035)

  • Online Retail
  • Pharmacies
  • Health Food Stores
  • Supermarkets
  • Specialty Stores

US Eye Health Supplements Market By Target Demographic (USD Million, 2026-2035)

  • Adults
  • Seniors
  • Children
  • Athletes
  • Professionals

US Eye Health Supplements Market By Ingredient Type (USD Million, 2026-2035)

  • Vitamins
  • Minerals
  • Herbal Extracts
  • Antioxidants
  • Omega Fatty Acids

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.